XBIXCorgi U.S. Biotech 2x Daily ETF
Seeks daily investment results that correlate to 2x the daily performance of the SPDR S&P Biotech ETF.
By Corgi Funds · Launched 2026
Annual Cost
0.45%
#2,318 of 6,033 · average
Fund Size
$0.6M
#5,873 of 6,033 · small
Return (1Y)
N/A
Track Record
3 months
#5,589 of 6,033 · young
Performance
Total-return NAV · USDGrowth of $10,000
$12,574+25.7%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaStrategy
Leveraged
Index tracked
S&P Biotechnology Select Industry Index
Holdings
By weightConcentration
synthetic exposure — holdings shown are derivatives collateral, not the fund's positions
First American Government Obligs XFGXXX
11.1%
Asset allocation
Stocks
199.3%
Other
2.9%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
N/A
Max drawdown
-20.8%Moderate
Worst peak-to-trough loss
Sharpe (3Y)
Unavailable
Needs 3+ years of history
Sortino (3Y)
Not yet
Needs 3+ years of history
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks daily investment results that correlate to 2x the daily performance of the SPDR S&P Biotech ETF.
- Strategy
- Actively managed ETF that seeks to achieve 2x daily exposure to U.S. biotechnology companies through derivatives, primarily total return swaps and equity futures. The Fund rebalances daily to maintain its leveraged exposure.
- Inception date
- June 2, 2026
- Fund family
- Corgi Funds
Similar funds
Same asset class, closest by strategy & exposureNext steps
Save XBIX to compare it with other funds, or start building a portfolio.
Data updated on 2026-09-16